XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share - Schedule of Reconciliation of Numerator and Denominator of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (31.7) $ (4.9) $ (59.6) $ (10.9)
Weighted average common shares outstanding:        
Basic (shares) 126,172 125,747 126,093 125,559
Diluted (shares) [1] 126,172 125,747 126,093 125,559
Net loss per share attributable to common stockholders:        
Basic (in USD per share) $ (0.25) $ (0.04) $ (0.47) $ (0.09)
Diluted (in USD per share) [1] $ (0.25) $ (0.04) $ (0.47) $ (0.09)
Stock options        
Net loss per share attributable to common stockholders:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,187 1,421 1,164 1,412
Restricted shares        
Net loss per share attributable to common stockholders:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 281 208 264 202
[1] The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.